本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Scinai Immunotherapeutics Ltd.

1.35
-0.1000-6.90%
盤後1.360.0137+1.01%16:28 EDT
成交量:14.58萬
成交額:20.31萬
市值:425.55萬
市盈率:0.23
高:1.47
開:1.47
低:1.31
收:1.45
52周最高:6.18
52周最低:1.31
股本:315.22萬
流通股本:294.75萬
量比:1.74
換手率:4.95%
股息:- -
股息率:- -
每股收益(TTM):5.95
每股收益(LYR):5.95
淨資產收益率:1791.99%
總資產收益率:-39.55%
市淨率:1.91
市盈率(LYR):0.23

資料載入中...

2025/09/22

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/05/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/12

SEC問詢函

Form CORRESP - Correspondence
2025/03/11

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/03/04

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/20

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/05/15

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/12

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

SEC問詢函

Form CORRESP - Correspondence
2024/01/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/26

SEC問詢函

Form CORRESP - Correspondence
2023/12/22

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/08/23

SEC問詢函

Form CORRESP - Correspondence
2023/06/08

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/04

重要事件披露

Form 8-K - Current report